When Abbott announced its FreeStyle Libre 3 device correction in November 2025, the company’s communications team had already established a verification website, deployed 24/7 customer support, and prepared replacement logistics. Seven deaths and 736 adverse events demanded nothing less. But the real test wasn’t the announcement, as îit was managing the narrative across global media, […]
Your Next Pharma Crisis Will Start in Someone’s Group Chat
Picture this: Tuesday, 10 p.m. Your Slack channel lights up. A TikTok video claiming your GLP-1 trial “shrunk kidneys” has exploded from 200 to 20,000 shares while you were brushing your teeth. That familiar knot forms in your stomach. Sound familiar? Recently at Ticket-to-Biotech, Angela Dwyer (FullIntel’s Head of Insights) and I explored how biotech […]


